Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle
Stefen A. Boehme
Biological Response Modifiers Program, National Cancer Institute, Bethesda
Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda
Search for more papers by this authorCorresponding Author
Michael J. Lenardo
Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda
LI, NIAID, National Institutes of Health, 9000 Rockville Pike, Building 10, Room 11N311, Bethesda, MD 20892, USA (Fax: 13014028530)Search for more papers by this authorStefen A. Boehme
Biological Response Modifiers Program, National Cancer Institute, Bethesda
Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda
Search for more papers by this authorCorresponding Author
Michael J. Lenardo
Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda
LI, NIAID, National Institutes of Health, 9000 Rockville Pike, Building 10, Room 11N311, Bethesda, MD 20892, USA (Fax: 13014028530)Search for more papers by this authorAbstract
We found that mature nontransformed CD4+ and CD8+ T lymphocytes could be made susceptible to T cell receptor(TcR)-mediated apoptosis by pretreatment with interleukin-4 (IL-4) or interleukin-2 (IL-2). The degree of susceptibility to death could be correlated with the level of cell cycling as measured by thymidine incorporation, cell doubling times, or the number of cells incorporating bromodeoxyuridine during S phase. However, using pharmacologic cell cycle blocking agents, we found that progression through the cell cycle was not required for cell death. Rather, we found that cells must be in a certain phase of the cell cycle to be susceptible to TcR-mediated death. Cells blocked in G1 phase were resistant to T cell receptor-induced apoptosis, whereas cells blocked in S phase were susceptible. These observations suggest that an important feature of growth lymphokines is their ability to drive T cells into portions of the cell cycle where they are sensitive to antigen receptor-induced apoptosis. Furthermore, these results provide additional evidence that the T cell growth lymphokines IL-2 and IL-4 may participate in the down-regulation of T cell responses by apoptosis a pathway we have termed “propriocidal regulation”.
References
- 1 J. F. R. Kerr and B. V. Harman, L. D. Tomei, F. O. Cope (Eds.)., Apoptosis: The Molecular Basis of Cell Death. Cold Spring Harbor Laboratory Press, Plainview, NY 1991, p. 5.
- 2 Lockshin, R. A. and Zakeri, Z., L. D. Tomei, F. O. Cope (Eds.)., Apoptosis: The Molecular Basis of Cell Death. Cold Spring Harbor Laboratory Press, Plainview, NY 1991, p. 47.
- 3 Cohen, J. J., Duke, R. C., Fadok V. A. and Sellins, K. S., Annu. Rev. Immunol. 1992. 10: 267.
- 4 Duvall, E. and Wyllie, A. H., Immunol. Today 1986. 7: 115.
- 5 Cotter, T. G., Lennon, S. V., Glynn J. G. and Martin, S. J., Anticancer Res. 1990. 10: 153.
- 6 Ucker, D. S., New Biologist 1991. 3: 103.
- 7 Cohen, J. J., Adv. Immunol. 1991. 50: 55.
- 8 Raff, M. C., Nature 1992. 356: 397.
- 9 von Boehmer, H., Annu. Rev. Immunol. 1988. 6: 309.
- 10 Marrack, P. and Kappler, J., Science 1987. 238: 1073.
- 11 Murphy, K. M., Heimberger A. B. and Loh, D. Y., Science 1990. 250: 1720.
- 12 Smith, C. A., Williams, G. T., Kingston, R., Jenkinson E. J. and Owen, J. T., Nature 1989. 337: 181.
- 13 Shi, Y., Bissonnette, R. P., Parfrey, N., Szalay, M., Kubo R. T. and Green, D. R., J. Immunol. 1991. 146: 3340.
- 14 McConkey, D. J., Hartzell, P., Amador-Perez, J. F., Orrenius, S. and Jondal, M., J. Immunol. 1989. 143: 1801.
- 15 Nieto, M. A., Gonzalez, A., Lopez-Rivas, A., Diaz-Espada, F. and Gambon, R., J. Immunol. 1990. 145: 1364.
- 16 Ashweli, J. D., Cunningham, R. E., Noguchi P. D. and Hernandez, D., J. Exp. Med. 1987. 165: 173.
- 17 Mercep, M., Bluestone, J. A., Noguchi P. D. and Ashwell, J. D., J. Immunol. 1988. 140: 324.
- 18 Ucker, D. S., Ashwell J. D. and Nickas, G., J. Immunol. 1989. 143: 3461.
- 19 Nickas, G., Meyers, J., Hebshi, L. D., Ashwell, J. D., Gold, D. P., Sydora, B. and Ucker, D. S., Mol. Cell. Biol. 1992. 12 379.
- 20 Shi, Y., Szalay, M. G., Paskar, L., Boyer, M., Singh, B. and Green, D. R., J. Immunol. 1990. 144: 3326.
- 21 Odaka, C., Kizaki, H. and Tadakuma, T., J. Immunol. 1990. 144: 2096.
- 22 Takahashi, S., Maecker H. T. and Levy, R., Eur. J. Immunol. 1989. 19: 1911.
- 23 Lenardo, M. J., Nature 1991. 353: 858.
- 24 Boehme S. A. and Lenardo, M. J., Leukemia 1993, in press.
- 25 Ucker, D. S., Meyers, J. and Obermiller, P. S., J. Immunol. 1992. 149: 1583.
- 26 Jones, L. A., Chin, L. T., Longo D. L. and Kruisbeek, A. M.. Science 1990. 250: 1726.
- 27 Webb, S., Morris, C. and Sprent, J., Cell 1990. 63: 1249.
- 28 Rocha, B. and von Boehmer, H., Science 1991. 251: 1225.
- 29 Kawabe, Y. and Ochi, A., Nature 1991. 349: 245.
- 30 Liu, Y. and Janeway, C. A. Jr., J. Exp. Med. 1990. 172: 1735.
- 31 Rellahan, B. L., Jones, L. A., Kruisbeek, A. M., Fry A. M. and Matis, L. A., J. Exp. Med. 1990. 172: 1091.
- 32 Duke R. C. and Cohen, J. J., Lymphokine Res. 1986. 5: 289.
- 33 Mossman, T. R., Cherwinski, H., Bond, M. W., Giedlin M. A. and Coffman, R. L., J. Immunol. 1986. 136: 2348.
- 34 Leo, O., Foo, M., Sachs, D. H., Samelson L. E. and Blue-stone, J. A., Proc. Natl. Acad. Sci. USA 1987. 84: 1374.
- 35 Kubo, R. T., Born, W., Kappler, J. W., Marrack, P. and Pigeon, M., J. Immunol. 1989. 142: 2736.
- 36 Ozato, K., Mayer N. M. and Sachs, D. H., Transplantation 1982. 34: 113.
- 37 Oi, V. T., Jones, P. P., Goding, J. W., Herzenberg L. A. and Herzenberg, L. A., Top. Microbiol. Immunol. 1978. 81: 115.
- 38 Lerner, E. A., Matis, L. A., Janeway, C. A., Jones, P. P., Schwartz R. H. and Murphy, D. B., J. Exp. Med. 1980. 152: 1085.
- 39 Kang, S.-M., Beverly, B., Tran, A.-C., Brorson, K., Schwartz R. H. and Lenardo, M. J., Science 1992. 257: 1134.
- 40 J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach and W. Strober (Eds.), Current Protocols in Immunology. John Wiley and Sons, New York 1992.
- 41 Hu-Li, J., Ohara, J., Watson, C., Tsang, W. and Paul, W. E., J. Immunol. 1989. 142: 800.
- 42 Mueller, D. L., Chiodetti, L., Bacon, P. A. and Schwartz, R. H., J. Immunol. 1991. 146: 4118.
- 43 Tanaka, T., Ben-Sasson, S. Z. and Paul, W. E., J. Immunol. 1991. 746: 3831.
- 44 Seder, B., Paul, W. E., Davis, M. and Fazekas de St. Growth, B., J. Exp. Med. 1992. 776: 1091.
- 45 Lalande, M., Exp. Cell Res. 1990. 786: 322.
- 46 Hoffman, B. D., Hanauske-Abel, H. M., Flint, A. and Lalande, M., Cytometry 1991. 12: 26.
- 47 Watson, P. A., Hanauske-Abel, H., Flint, A. and Lalande, M., Cytometry 1991. 72: 242.
- 48 Terada, N., Lucas J. J. and Gelfand, E. W., J Immunol. 1991. 747: 698.
- 49 Lingk, D. S., Chan M. A. and Gelfand, E. W., J. Immunol. 1990. 145: 449.
- 50 Johnson, K. W., Davis B. H. and Smith, K. A., Proc. Natl. Acad. Sci. USA 1988. 85: 6072.
- 51 Huberman, J. A., Cell 1981. 23: 647.
- 52 R. L. P. Adams, R. H. Burdon, A. M. Campbell, D. P. Leader and R. M. S. Smellie (Eds.), The Biochemistry of the Nucleic Acids. Chapman and Hall, New York 1981.
- 53 Trowell, O. A., J. Pathol. Bacteriol. 1952. 64: 687.
- 54 Barry, M. A., Behnke C. A. and Eastman, A., Biochem. Pharmacol. 1990. 40: 2353.
- 55 McConkey, D. J., Hartzell, P., Nicotera, P. and Orrenius, S., FASEB J. 1989. 3: 1843.
- 56 Kung, A. L., Zetterberg, A., Sherwood S. W. and Schimke, R. T., Cancer Res. 1990. 50: 7307.
- 57 Barres, B. A., Hart, I. K., Coles, H. S. R., Burne, J. E., Voyvodic, J. T., Richardson W. D. and Raff, M. C., Cell 1992. 70: 31.
- 58 Duke, R. C., Cohen J. J. and Chervenak, R., J. Immunol. 1986. 137: 1442.
- 59 Wyllie, A. H., Nature 1980. 284: 555.